A Treatment to Cure Diabetes Using Plant-Based Drug Discovery
Sumalatha Mahankali, Jagadish Kalava, Yugandhar Garapati, Bullarao Domathoti, Venkata Rao Maddumala, Venkatesa Prabhu Sundramurty
Abstract
The field of peptides and proteins has opened up new doors for plant-based medication development because of analytical breakthroughs. Enzymatic breakdown of plant-specific proteins yields bioactive peptides. These plant-based proteins and peptides, in addition to their in vitro and vivo outcomes for diabetes treatment, are discussed in this study. The secondary metabolites of vegetation can interfere with the extraction, separation, characterization, and commercialization of plant proteins through the pharmaceutical industry. Glucose-lowering diabetic peptides are a hot commodity. For a wide range of illnesses, bioactive peptides from flora can offer up new avenues for the development of cost-effective therapy options.